Expanding the functional spectrum of vitamin K in bone. Focus on: "Vitamin K promotes mineralization, osteoblast to osteocyte transition, and an anti-catabolic phenotype by γ-carboxylation-dependent and -independent mechanisms"

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 6, 2009, Pages

  Rubinacci, Alessandro ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; CALCIUM; VITAMIN K GROUP;

BINDING SITE; BLOOD CLOTTING; BONE CELL; BONE MINERAL; BONE MINERALIZATION; CALCIUM BINDING; CALCIUM CELL LEVEL; CARBOXYLATION; CATABOLISM; CELL TRANSFORMATION; EDITORIAL; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN PROCESSING; TRABECULAR BONE; ANIMAL; BONE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; METABOLISM; NOTE; PHENOTYPE; PHYSIOLOGY;

1-CARBOXYGLUTAMIC ACID; ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; HUMANS; METABOLISM; OSTEOBLASTS; OSTEOCYTES; PHENOTYPE; VITAMIN K;

EID: 73449095297     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00452.2009     Document Type: Editorial

References (34)

1. Almquist HJ. The early hystory of vitamin K. Am J Clin Nutr 28: 656-9, 1975.
2. Atkins GJ, Welldon KJ, Wijenayaka AR, Bonewald L, Findlay DM. Vitamin K promotes mineralization, osteoblast to osteocyte transition, and an anti-catabolic phenotype by γ-carboxylation-dependent and -independent mechanisms. Am J Physiol Cell Physiol (Aug 12,2009). doi:10.1152/ajpcell. 00216.2009.
3. Booth SL. Roles for vitamin K. Beyond coagulation. Annu Rev Nutr 29: 89-110, 2009.
4. Boskey Al Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23: 187-196, 1998.
5. Coen G, Ballanti P, Silvestrini G, Mantella D, Manni M, Di Giulio S, Pisanò S, Leopizzi M, Di Lullo G, Bonucci E. Immunohistochemical localization, and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients. Virchows Arch 454: 263-271, 2009.
6. Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J. Periostin, a member of a novel family of vitamin K.-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 283: 17991-18001, 2008.
7. Dam H. The antihaemorrhagic vitamin of the chick: occurrence and chemical nature. Nature 135: 652-653, 1935.
8. Dam H. The Discovery of Vitamin K, Its Biological Functions And Therapeuthical Application. Nobel Lecture, December 12, 1946.
9. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875-884, 2000.
10. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105: 5266-5270, 2008.
11. Hara K, Akiyama Y, Nakamura T, Murota S, Morita I. The inhibitory effect of vitamin K.2 (menatetrenone) on bone resorption may be related to its side chain. Bone 16: 179-184, 1995.
12. Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid, γ-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA 72: 3925-3929, 1975.
13. Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B, Inoue S. Steroid, and xenobiotic receptor S.X.R. mediates vitamin K.2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem 281: 16927-16934, 2006.
14. 2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells. J Mol Endocrinol 39: 239-247, 2007.
15. Kassi E, Papavassiliou AG. A possible role of osteocalcin in the regulation of insulin secretion: human in vivo evidence? J Endocrinol 199: 151-153, 2008.
16. Katsuyama H, Otsuki T, Tomita M, Fukunaga M, Fukunaga T, Suzuki N, Saijoh K, Fushimi S, Sunami S. Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. Int J Mol Med 15: 231-236, 2005.
17. Krueger T, Westenfeld R, Schurgers L, Brandenburg V. Coagulation meets calcification: the vitamin K system. Int J Artif Organs 32: 67-74, 2009.
18. Laizé V, Martel P, Viegas CSB, Price PA, Cancela ML. Evolution of matrix, and bone γ-carboxyglutamic acid proteins in vertebrates. J Biol Chem 280: 26659-26668, 2005.
19. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456-69, 2007.
20. Maillard C, Berruyer M, Serre CM, Dechavanne M, Delmas PD. Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology 130: 1599-1604, 1992.
21. Marenzana M, Shipley AM, Squitiero P, Kunkel JG, Rubinacci A. Bone as an ion exchange organ: evidence for instantaneous cell-dependent calcium efflux from bone not due to resorption. Bone 37: 545-554, 2005.
22. Morishita M, Nagashima M, Wauke K, Takahashi H, Takenouchi K. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. J Rheumatol 35: 407-413, 2008.
23. Murshed M, Schinke T, McKee MD, Karsenty G. Extracellular matrix mineralization is regulated locally: different roles of two gla-containing proteins. J Cell Biol 165: 625-630, 2004.
24. Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem 249: 6347-6350, 1974.
25. Price PA, Urist MR, Otawara Y. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 117: 765-771, 1983.
26. Rani S, Barbe M, Barr A, Litvin J. Periostin-like-factor and periostin in an animal model of work-related musculoskeletal disorder. Bone 44: 502-512, 2009.
27. Schurgers LJ, Teunissen KJF, Knapen MHJ, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JPM, Vermeer C. Novel conformation-specific antibodies against matrix γ-carboxyglutamic acid (Gla) protein-undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 25: 1629-1633, 2005.
28. Seeman E, Delmas PD. Bone quality - the material, and structural basis of bone strength and fragility. N Engl J Med 354: 2250-2261, 2006.
29. Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 71: 2730-2733, 1974.
30. Suhara Y, Wada A, Okano T. Elucidation of the mechanism producing menaquinone-4 in osteoblastic cells Bioorg. Med Chem Lett 19: 1054-1057, 2009.
31. Suttie JW. Vitamin K-dependent carboxylase. Ann Rev Biochem 54 : 459-477, 1985.
32. Tabb MM, Sun A, Zhou C, Grün F, Errandi J, Romero K, Pham H, Inoue S, Mallick S, Lin M, Forman BM, Blumberg B. Vitamin K2 regulation of bone homeostasis is mediated by the steroid, and xenobiotic receptor SXR. J Biol Chem 278: 43919-43927, 2003.
33. Talmage RV, Mobley HT. The concentration of free calcium in plasma is set by the extracellular action of noncollagenous proteins and hydroxyapatite. Gen Comp Endocrinol 162: 245-250, 2009.
34. Viegas CS, Simes DC, Laizeacute; V, Williamson MK, Price PA, Cancela ML. Gla-rich protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage, and highly conserved in vertebrates. J Biol Chem 283: 36655-36664, 2008.